Complete nucleotide sequence of pHN7A8, an F33:A-:B-type epidemic plasmid carrying blaCTX-M-65, fosA3 and rmtB from China
Open Access
- 14 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 68 (1), 46-50
- https://doi.org/10.1093/jac/dks369
Abstract
To characterize a representative self-transmissible multidrug resistance plasmid pHN7A8 isolated from an Escherichia coli from a dog in China, classified as F33:A-:B- by replicon sequence typing and carrying the blaTEM-1b, blaCTX-M-65, fosA3 and rmtB genes conferring resistance to penicillins, cephalosporins, fosfomycin and aminoglycosides, respectively. pHN7A8 was sequenced using a whole-genome shotgun approach and the sequence analysed by comparison with reference plasmids. pHN7A8 is a circular molecule of 76 878 bp. blaCTX-M-65, fosA3 and rmtB are found in known contexts, interspersed with different mobile elements including ISEcp1, IS1, Tn2, IS1294, IS903 and four copies of IS26. This multiresistance region has only a single nucleotide difference from that of pXZ, an F2:A-:B- plasmid isolated from poultry in China. The pHN7A8 backbone carries genes encoding addiction and partitioning systems that promote plasmid maintenance and has a similar organization to pXZ, as well as IncFII plasmids such as R100, pC15-1a/pEK516 and pHK23, isolated in Japan, Canada/the UK and China, respectively, but with varying levels of identity, suggesting recombination. pHN7A8 is a chimera that may have resulted from the acquisition, by recombination in the plasmid backbone, of the multiresistance region found in pXZ. This region appears to have evolved from the resistance determinant R100 through the stepwise integration of multiple antimicrobial resistance determinants from different sources by the actions of mobile elements and recombination. The successful dissemination of this multidrug resistance plasmid presents further challenges for the prevention and treatment of Enterobacteriaceae infections.This publication has 19 references indexed in Scilit:
- Dissemination of the Fosfomycin Resistance Gene fosA3 with CTX-M β-Lactamase Genes and rmtB Carried on IncFII Plasmids among Escherichia coli Isolates from Pets in ChinaAntimicrobial Agents and Chemotherapy, 2012
- F33:A−:B− and F2:A−:B− Plasmids Mediate Dissemination of rmtB-bla CTX-M-9 Group Genes and rmtB-qepA in Enterobacteriaceae Isolates from Pets in ChinaAntimicrobial Agents and Chemotherapy, 2011
- Sequence Type ST405 Escherichia coli Isolate Producing QepA1, CTX-M-15, and RmtB from Detroit, MichiganAntimicrobial Agents and Chemotherapy, 2011
- Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in AustraliaAntimicrobial Agents and Chemotherapy, 2010
- Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying EnzymesAntimicrobial Agents and Chemotherapy, 2010
- Pathogenomics of the Virulence Plasmids ofEscherichia coliMicrobiology and Molecular Biology Reviews, 2009
- Complete Nucleotide Sequences of Plasmids pEK204, pEK499, and pEK516, Encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 CloneAntimicrobial Agents and Chemotherapy, 2009
- Resistance Plasmid Families in EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2009
- Widespread Dissemination of Aminoglycoside Resistance Genes armA and rmtB in Klebsiella pneumoniae Isolates in Taiwan Producing CTX-M-Type Extended-Spectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 2009
- Escherichia coli Isolate Coproducing 16S rRNA Methylase and CTX-M-Type Extended-Spectrum β-Lactamase Isolated from an Outpatient in the United StatesAntimicrobial Agents and Chemotherapy, 2008